title: The promises and pitfalls of pharmacoeconomics in schizophrenia.
authors.affiliation: Institute of Psychiatry, Centre for the Economics of Mental Health, Box PO24, The David Goldberg De Crespigny Park, London, UK. a.patel@iop.kcl.ac.uk
authors.forename: Anita
authors.initials: A
authors.lastname: Patel
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000191:economics*; D057186:Comparative Effectiveness Research / Q000706:statistics & numerical data; D016001:Confidence Intervals; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D019468:Disease Management; D064420:Drug-Related Side Effects and Adverse Reactions / Q000191:economics*; D017850:Economics, Pharmaceutical / Q000706:statistics & numerical data; D005060:Europe; D006760:Hospitalization / Q000191:economics; D006801:Humans; D008605:Mental Health Services / Q000191:economics; D011788:Quality of Life; D012050:Rehabilitation, Vocational / Q000191:economics; D012559:Schizophrenia / Q000191:economics / Q000628:therapy; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents